Cargando…

Severity of Experimental Autoimmune Uveitis Is Reduced by Pretreatment with Live Probiotic Escherichia coli Nissle 1917

Non-infectious uveitis is considered an autoimmune disease responsible for a significant burden of blindness in developed countries and recent studies have linked its pathogenesis to dysregulation of the gut microbiota. We tested the immunomodulatory properties of two probiotics, Escherichia coli Ni...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dusek, Otakar, Fajstova, Alena, Klimova, Aneta, Svozilkova, Petra, Hrncir, Tomas, Kverka, Miloslav, Coufal, Stepan, Slemin, Johan, Tlaskalova-Hogenova, Helena, Forrester, John V., Heissigerova, Jarmila
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823395/ https://www.ncbi.nlm.nih.gov/pubmed/33375578 http://dx.doi.org/10.3390/cells10010023

Ejemplares similares

The Microbiota Determines Susceptibility to Experimental Autoimmune Uveoretinitis
por: Heissigerova, Jarmila, et al.
Publicado: (2016)

Diet Rich in Simple Sugars Promotes Pro-Inflammatory Response via Gut Microbiota Alteration and TLR4 Signaling
por: Fajstova, Alena, et al.
Publicado: (2020)

Urinary Intestinal Fatty Acid-Binding Protein Can Distinguish Necrotizing Enterocolitis from Sepsis in Early Stage of the Disease
por: Coufal, Stepan, et al.
Publicado: (2016)

Urinary I-FABP, L-FABP, TFF-3, and SAA Can Diagnose and Predict the Disease Course in Necrotizing Enterocolitis at the Early Stage of Disease
por: Coufal, Stepan, et al.
Publicado: (2020)

Administration of a Probiotic Can Change Drug Pharmacokinetics: Effect of E. coli Nissle 1917 on Amidarone Absorption in Rats
por: Matuskova, Zuzana, et al.
Publicado: (2014)

Diet Rich in Animal Protein Promotes Pro-inflammatory Macrophage Response and Exacerbates Colitis in Mice
por: Kostovcikova, Klara, et al.
Publicado: (2019)

The Prevalence of MRI-Defined Sacroiliitis and Classification of Spondyloarthritis in Patients with Acute Anterior Uveitis: A Longitudinal Single-Centre Cohort Study
por: Bubova, Kristyna, et al.
Publicado: (2022)

Immune Privilege: The Microbiome and Uveitis
por: Mölzer, Christine, et al.
Publicado: (2021)

Gut Microbiota and NAFLD: Pathogenetic Mechanisms, Microbiota Signatures, and Therapeutic Interventions
por: Hrncir, Tomas, et al.
Publicado: (2021)

Inflammatory Bowel Disease Types Differ in Markers of Inflammation, Gut Barrier and in Specific Anti-Bacterial Response
por: Coufal, Stepan, et al.
Publicado: (2019)

P1240: MICROBIOME DIVERSITY IN PATIENTS WITH LYMPHOMA
por: Dlouha, Lucie, et al.
Publicado: (2023)

Bioengineered Escherichia coli Nissle 1917 for tumour‐targeting therapy
por: Yu, Xiaoli, et al.
Publicado: (2019)

Sperm Cells Induce Distinct Cytokine Response in Peripheral Mononuclear Cells from Infertile Women with Serum Anti-Sperm Antibodies
por: Kverka, Miloslav, et al.
Publicado: (2012)

Gradient Magnetic Field Accelerates Division of E. coli Nissle 1917
por: Gorobets, Svitlana, et al.
Publicado: (2023)

Lipopolysaccharide treatment suppresses spontaneously developing ankylosing enthesopathy in B10.BR male mice: The potential role of interleukin-10
por: Capkova, Jana, et al.
Publicado: (2012)

The intestinal fatty acid-binding protein as a marker for intestinal damage in gastroschisis
por: Kokesova, Alena, et al.
Publicado: (2019)

A possible coincidence of cytomegalovirus retinitis and intraocular lymphoma in a patient with systemic non-Hodgkin’s lymphoma
por: Svozílková, Petra, et al.
Publicado: (2013)

Identification of an analgesic lipopeptide produced by the probiotic Escherichia coli strain Nissle 1917
por: Pérez-Berezo, Teresa, et al.
Publicado: (2017)

Deciphering the interplay between the genotoxic and probiotic activities of Escherichia coli Nissle 1917
por: Massip, Clémence, et al.
Publicado: (2019)

Escherichiacoli Nissle 1917 as a Novel Microrobot for Tumor-Targeted Imaging and Therapy
por: Liu, Qingyao, et al.
Publicado: (2021)

Development of gut inflammation in mice colonized with mucosa-associated bacteria from patients with ulcerative colitis
por: Du, Zhengyu, et al.
Publicado: (2015)

Gut microbiota and lipopolysaccharide content of the diet influence development of regulatory T cells: studies in germ-free mice
por: Hrncir, Tomas, et al.
Publicado: (2008)

Probiotic Escherichia coli Nissle 1917 Inhibits Leaky Gut by Enhancing Mucosal Integrity
por: Ukena, Sya N., et al.
Publicado: (2007)

E. coli Nissle 1917 Affects Salmonella Adhesion to Porcine Intestinal Epithelial Cells
por: Schierack, Peter, et al.
Publicado: (2011)

The Probiotic Escherichia coli Strain Nissle 1917 Combats Lambdoid Bacteriophages stx and λ
por: Bury, Susanne, et al.
Publicado: (2018)

The Administration of Escherichia coli Nissle 1917 Ameliorates Development of DSS-Induced Colitis in Mice
por: Rodríguez-Nogales, Alba, et al.
Publicado: (2018)

Engineered E. coli Nissle 1917 for the reduction of vancomycin‐resistant Enterococcus in the intestinal tract
por: Geldart, Kathryn G., et al.
Publicado: (2018)

Effects of Escherichia coli strain Nissle 1917 on exercise-induced disruption of gastrointestinal integrity
por: Mooren, F. C., et al.
Publicado: (2020)

Transcriptional Profiling of the Probiotic Escherichia coli Nissle 1917 Strain under Simulated Microgravity
por: Yim, Jaewoo, et al.
Publicado: (2020)

Engineered E. coli Nissle 1917 for the delivery of matrix-tethered therapeutic domains to the gut
por: Praveschotinunt, Pichet, et al.
Publicado: (2019)

No Genotoxicity Is Detectable for Escherichia coli Strain Nissle 1917 by Standard In Vitro and In Vivo Tests
por: Dubbert, Silke, et al.
Publicado: (2020)

Anti-inflammatory properties of Escherichia coli Nissle 1917 in a murine colitis model
por: Park, Jihye, et al.
Publicado: (2021)

Plasmid Vectors for in Vivo Selection-Free Use with the Probiotic E. coli Nissle 1917
por: Kan, Anton, et al.
Publicado: (2020)

Escherichia coli Nissle 1917 inhibits biofilm formation and mitigates virulence in Pseudomonas aeruginosa
por: Aljohani, Ahmad M., et al.
Publicado: (2023)

Engineered E. coli Nissle 1917 for delivery of bioactive IL-2 for cancer immunotherapy
por: Tumas, Sarunas, et al.
Publicado: (2023)

Patterns of Early Gut Colonization Shape Future Immune Responses of the Host
por: Hansen, Camilla Hartmann Friis, et al.
Publicado: (2012)

Crucial Role of Microbiota in Experimental Psoriasis Revealed by a Gnotobiotic Mouse Model
por: Stehlikova, Zuzana, et al.
Publicado: (2019)

Genotoxicity of Escherichia coli Nissle 1917 strain cannot be dissociated from its probiotic activity
por: Olier, Maïwenn, et al.
Publicado: (2012)

Functional investigation of the chromosomal ccdAB and hipAB operon in Escherichia coli Nissle 1917
por: Xu, Jun, et al.
Publicado: (2020)

A Toxic Friend: Genotoxic and Mutagenic Activity of the Probiotic Strain Escherichia coli Nissle 1917
por: Nougayrède, Jean-Philippe, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sg6s0gp6ofnec2gvmhjiali9pd